Efficacy of TCA Effect on Varicella Atrophic Scars

NCT ID: NCT00422539

Last Updated: 2007-01-17

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

PHASE2

Total Enrollment

100 participants

Study Classification

INTERVENTIONAL

Study Start Date

2006-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study aims to determine the efficacy of 70% trichloroacetic acid on atrophic scars of varicella

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

high concentration trichloroacetic acid peeling has been shown to be effective in treating and flattening the atrophic acne scars. According to the lack of an effective and low cost therapy for removing these relative common and nuisance lesions; We aimed to answer that whether we could achieve the same results from 70% TCA on atrophic varicella scars.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Atrophic Varicella Scar

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

70% trichloroacetic acid

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Atrophic varicella scar on face

Exclusion Criteria

* Active varicella infection
* Active Herpetic infection
* Previous history of keloid formation
Minimum Eligible Age

15 Years

Maximum Eligible Age

45 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Shahid Beheshti University of Medical Sciences

OTHER

Sponsor Role lead

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Parviz Toossi, M.D.

Role: STUDY_CHAIR

Skin Research Center of Shaheed Beheshti medical University

Behrooz Barikbin, M.D.

Role: PRINCIPAL_INVESTIGATOR

Skin Research Center of Shaheed Beheshti Medical Universty

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Skin Research Center, Shohada-e Tajrish Hospital, shaheed Beheshti Medical University

Tehran, Tehran Province, Iran

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Iran

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Behrooz Barikbin, M.D.

Role: CONTACT

98-21-22744393 ext. 5

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

SRC-BBA-1385-6-1

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.